Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease
KG Tolman, V Fonseca, A Dalpiaz, MH Tan - Diabetes care, 2007 - Am Diabetes Assoc
METHODS—A Medline search without limitations of date (as of October 2005), language, or
humans was carried out by the authors. The following medical subject headings were …
humans was carried out by the authors. The following medical subject headings were …
The liver and lovastatin
KG Tolman - The American journal of cardiology, 2002 - Elsevier
The cholesterol-lowering agents, known as statins, have been in use for 15 years and are
among the most commonly prescribed drugs. Animal studies and premarketing clinical trials …
among the most commonly prescribed drugs. Animal studies and premarketing clinical trials …
The therapeutic use of acetaminophen in patients with liver disease
GD Benson, RS Koff, KG Tolman - American journal of …, 2005 - journals.lww.com
Acetaminophen has been used safely and effectively for many years to manage pain and/or
fever in patients of all ages. It is commonly recommended as first-line therapy for a variety of …
fever in patients of all ages. It is commonly recommended as first-line therapy for a variety of …
Determinants of serious liver disease among patients receiving low‐dose methotrexate for rheumatoid arthritis
Objective. To assess the risk of serious liver disease in patients with rheumatoid arthritis
(RA) taking methotrexate (MTX). Methods. We surveyed members of the American College …
(RA) taking methotrexate (MTX). Methods. We surveyed members of the American College …
Liver histology in rheumatoid arthritis patients receiving long‐term methotrexate therapy. A prospective study with baseline and sequential biopsy samples
JM Kremer, RG Lee, KG Tolman - Arthritis & Rheumatism …, 1989 - Wiley Online Library
Twenty‐nine patients with active rheumatoid arthritis receiving long‐term oral weekly
methotrexate (MTX) therapy were studied to determine the extent of their hepatic …
methotrexate (MTX) therapy were studied to determine the extent of their hepatic …
Narrative review: hepatobiliary disease in type 2 diabetes mellitus
KG Tolman, V Fonseca, MH Tan… - Annals of internal …, 2004 - acpjournals.org
Diabetes mellitus is the fifth leading cause of death in the United States; 17 million people
are affected. Liver disease is one of the leading causes of death in persons with type 2 …
are affected. Liver disease is one of the leading causes of death in persons with type 2 …
Treatment of non-alcoholic fatty liver disease
KG Tolman, AS Dalpiaz - Therapeutics and clinical risk …, 2007 - Taylor & Francis
Non-alcoholic fatty liver disease, defined as the presence of macrovascular steatosis in the
presence of less than 20 gm of alcohol ingestion per day, is the most common liver disease …
presence of less than 20 gm of alcohol ingestion per day, is the most common liver disease …
Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men
AW Meikle, NA Mazer, JF Moellmer… - The Journal of …, 1992 - academic.oup.com
None of the current or experimental androgen treatment modalities for male hypogonadism
has been reported to produce physiological concentrations or circadian variations in …
has been reported to produce physiological concentrations or circadian variations in …
Hepatotoxicity of non-narcotic analgesics
KG Tolman - The American journal of medicine, 1998 - Elsevier
The central role of the liver in drug metabolism sets the stage for drug-related hepatotoxicity.
The incidence of hepatotoxicity associated with non-narcotic analgesics is low, but their …
The incidence of hepatotoxicity associated with non-narcotic analgesics is low, but their …
Hepatotoxicity of the thiazolidinediones
KG Tolman, J Chandramouli - Clinics in Liver Disease, 2003 - liver.theclinics.com
Diabetes mellitus is the fourth leading cause of death in the United States [1], affecting an
estimated 16 million people or 7% of the population [2, 3]. The economic impact is estimated …
estimated 16 million people or 7% of the population [2, 3]. The economic impact is estimated …